Movahedi Mohammad, Afsharfard Abolfazl, Moradi Afshin, Nasermoaddeli Ali, Khoshnevis Jalaladdin, Fattahi Farinaz, Akbari Mohammad Esmail
Cancer Research Centre, Shahid Beheshti University of Medical Science, Tehran, Iran.
J Res Med Sci. 2009 Nov;14(6):367-73.
Stomach cancer is one of the most common malignancies worldwide. In Iran, the mortality of stomach cancer is the first cause of death due to cancer in both sexes. This study was designed to estimate survival rate of stomach cancer at national level.
From the national cancer registry file, 3439 cases of stomach cancer that had telephone number and were diagnosed between years 2001 and 2005 were called to obtain information about their life status. Survival estimates were calculated using the Kaplan-Meier method, and the survival probability was calculated for the overall cohorts and also for gender and anatomical sites of tumor. Relative ratios (RR) according to demographic and risk variables were calculated by Cox's proportional hazard model.
The overall 5-year survival rate was 12.8%. The likelihood of death was higher in men (RR = 1.21; 95% CI: 1.11-1.33) and patients more than 70 years old had worse prognosis rather than those below fifty years old (RR = 1.67; 95% CI: 1.46-1.91). The 5-year survival rate for tumors located in antrum was significantly higher than corpus and cardia (p = 0.009). Patients with lymphoma had a significantly higher 5-year survival rate compared to those with adenocarcinoma (RR = 0.46; 95% CI: 0.31-0.66).
The status of stomach cancer, including relative low survival rate in Iran, indicates the extremely urgent needs for health authorities to adopt measures of cancer prevention that proved effective in other countries.
胃癌是全球最常见的恶性肿瘤之一。在伊朗,胃癌死亡率是男女因癌症死亡的首要原因。本研究旨在估计全国范围内胃癌的生存率。
从国家癌症登记档案中,选取3439例有电话号码且在2001年至2005年期间被诊断为胃癌的病例,致电获取其生存状况信息。采用Kaplan-Meier方法计算生存估计值,并计算总体队列以及按性别和肿瘤解剖部位的生存概率。根据人口统计学和风险变量的相对比率(RR)通过Cox比例风险模型计算。
总体5年生存率为12.8%。男性死亡可能性更高(RR = 1.21;95%置信区间:1.11 - 1.33),70岁以上患者的预后比50岁以下患者更差(RR = 1.67;95%置信区间:1.46 - 1.91)。位于胃窦的肿瘤5年生存率显著高于胃体和贲门(p = 0.009)。与腺癌患者相比,淋巴瘤患者的5年生存率显著更高(RR = 0.46;95%置信区间:0.31 - 0.66)。
伊朗胃癌的现状,包括相对较低的生存率,表明卫生当局迫切需要采取在其他国家已证明有效的癌症预防措施。